- Home
- / TSH Biopharm
TSH Biopharm
Stock Price
NT$64.5
2024-10-29
Market Capitalization
NT$2.5 B
2024-10-29
Revenue
NT$1.3 B
FY, 2025
TSH Biopharm Summary
Company Summary
- Overview
- TSH Biopharm (東生華製藥股份有限公司) is a pharmaceutical company focused on chronic diseases. It offers prescription medications for cardiovascular, gastrointestinal, and central nervous system diseases. The company also provides liquid biopsy tests for cancer.
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- TW | view all locations
- Website
- http://www.tshbiopharm.com/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Taipei City HQ
Taiwan
Nangang District
TSH Biopharm Financials
Summary Financials
- Revenue (FY, 2025)
- NT$1.3B
- Gross profit (FY, 2025)
- NT$709.7M
- Net income (FY, 2025)
- NT$187.8M
- Cash (FY, 2025)
- NT$464.5M
- EBIT (FY, 2025)
- NT$220.6M
- Enterprise value
- $2.0B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026